145 related articles for article (PubMed ID: 25963478)
1. A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases.
Meyer JJ; Foster RD; Lev-Cohain N; Yokoo T; Dong Y; Schwarz RE; Rule W; Tian J; Xie Y; Hannan R; Nedzi L; Solberg T; Timmerman R
Ann Surg Oncol; 2016 Jan; 23(1):218-24. PubMed ID: 25963478
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
Folkert MR; Meyer JJ; Aguilera TA; Yokoo T; Sanford NN; Rule WG; Mansour J; Yopp A; Polanco P; Hannan R; Nedzi LA; Timmerman RD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1387-1395. PubMed ID: 33340601
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
Schefter TE; Kavanagh BD; Timmerman RD; Cardenes HR; Baron A; Gaspar LE
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1371-8. PubMed ID: 16029795
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
8. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
[TBL] [Abstract][Full Text] [Related]
11. Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.
Van De Voorde L; Vanneste B; Houben R; Damen P; van den Bogaard J; Lammering G; Dejong K; de Vos-Geelen J; Buijsen J; Öllers M; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Feb; 41(2):249-56. PubMed ID: 25468743
[TBL] [Abstract][Full Text] [Related]
12. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
13. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
Andratschke NH; Nieder C; Heppt F; Molls M; Zimmermann F
Radiat Oncol; 2015 Mar; 10():69. PubMed ID: 25889512
[TBL] [Abstract][Full Text] [Related]
17. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.
Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial.
Herfarth KK; Debus J; Lohr F; Bahner ML; Rhein B; Fritz P; Höss A; Schlegel W; Wannenmacher MF
J Clin Oncol; 2001 Jan; 19(1):164-70. PubMed ID: 11134209
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Ablative Radiotherapy for the Management of Liver Metastases from Neuroendocrine Neoplasms: A Preliminary Study.
Hudson JM; Chung HT; Chu W; Taggar A; Davis LE; Hallet J; Law CHL; Singh S; Myrehaug S
Neuroendocrinology; 2022; 112(2):153-160. PubMed ID: 33530088
[TBL] [Abstract][Full Text] [Related]
20. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.
Le QT; Loo BW; Ho A; Cotrutz C; Koong AC; Wakelee H; Kee ST; Constantinescu D; Whyte RI; Donington J
J Thorac Oncol; 2006 Oct; 1(8):802-9. PubMed ID: 17409963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]